186 related articles for article (PubMed ID: 23937597)
1. Marijuana's dose-dependent effects in daily marijuana smokers.
Ramesh D; Haney M; Cooper ZD
Exp Clin Psychopharmacol; 2013 Aug; 21(4):287-93. PubMed ID: 23937597
[TBL] [Abstract][Full Text] [Related]
2. Opioid antagonism enhances marijuana's effects in heavy marijuana smokers.
Cooper ZD; Haney M
Psychopharmacology (Berl); 2010 Aug; 211(2):141-8. PubMed ID: 20490465
[TBL] [Abstract][Full Text] [Related]
3. Subjective and physiological effects, and expired carbon monoxide concentrations in frequent and occasional cannabis smokers following smoked, vaporized, and oral cannabis administration.
Newmeyer MN; Swortwood MJ; Abulseoud OA; Huestis MA
Drug Alcohol Depend; 2017 Jun; 175():67-76. PubMed ID: 28407543
[TBL] [Abstract][Full Text] [Related]
4. Comparison of subjective, pharmacokinetic, and physiological effects of marijuana smoked as joints and blunts.
Cooper ZD; Haney M
Drug Alcohol Depend; 2009 Aug; 103(3):107-13. PubMed ID: 19443132
[TBL] [Abstract][Full Text] [Related]
5. Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis.
Haney M; Malcolm RJ; Babalonis S; Nuzzo PA; Cooper ZD; Bedi G; Gray KM; McRae-Clark A; Lofwall MR; Sparenborg S; Walsh SL
Neuropsychopharmacology; 2016 Jul; 41(8):1974-82. PubMed ID: 26708108
[TBL] [Abstract][Full Text] [Related]
6. Effects of tetrahydrocannabinol content on marijuana smoking behavior, subjective reports, and performance.
Heishman SJ; Stitzer ML; Yingling JE
Pharmacol Biochem Behav; 1989 Sep; 34(1):173-9. PubMed ID: 2560548
[TBL] [Abstract][Full Text] [Related]
7. Effect of oral THC pretreatment on marijuana cue-induced responses in cannabis dependent volunteers.
Lundahl LH; Greenwald MK
Drug Alcohol Depend; 2015 Apr; 149():187-93. PubMed ID: 25725933
[TBL] [Abstract][Full Text] [Related]
8. Cognitive and psychomotor effects in males after smoking a combination of tobacco and cannabis containing up to 69 mg delta-9-tetrahydrocannabinol (THC).
Hunault CC; Mensinga TT; Böcker KB; Schipper CM; Kruidenier M; Leenders ME; de Vries I; Meulenbelt J
Psychopharmacology (Berl); 2009 May; 204(1):85-94. PubMed ID: 19099294
[TBL] [Abstract][Full Text] [Related]
9. Neurophysiological and subjective profile of marijuana with varying concentrations of cannabinoids.
Ilan AB; Gevins A; Coleman M; ElSohly MA; de Wit H
Behav Pharmacol; 2005 Sep; 16(5-6):487-96. PubMed ID: 16148455
[TBL] [Abstract][Full Text] [Related]
10. Dronabinol and marijuana in HIV(+) marijuana smokers: acute effects on caloric intake and mood.
Haney M; Rabkin J; Gunderson E; Foltin RW
Psychopharmacology (Berl); 2005 Aug; 181(1):170-8. PubMed ID: 15778874
[TBL] [Abstract][Full Text] [Related]
11. A study investigating the acute dose-response effects of 13 mg and 17 mg Delta 9- tetrahydrocannabinol on cognitive-motor skills, subjective and autonomic measures in regular users of marijuana.
Weinstein A; Brickner O; Lerman H; Greemland M; Bloch M; Lester H; Chisin R; Sarne Y; Mechoulam R; Bar-Hamburger R; Freedman N; Even-Sapir E
J Psychopharmacol; 2008 Jun; 22(4):441-51. PubMed ID: 18635724
[TBL] [Abstract][Full Text] [Related]
12. Nabilone decreases marijuana withdrawal and a laboratory measure of marijuana relapse.
Haney M; Cooper ZD; Bedi G; Vosburg SK; Comer SD; Foltin RW
Neuropsychopharmacology; 2013 Jul; 38(8):1557-65. PubMed ID: 23443718
[TBL] [Abstract][Full Text] [Related]
13. An exploratory study of the combined effects of orally administered methylphenidate and delta-9-tetrahydrocannabinol (THC) on cardiovascular function, subjective effects, and performance in healthy adults.
Kollins SH; Schoenfelder EN; English JS; Holdaway A; Van Voorhees E; O'Brien BR; Dew R; Chrisman AK
J Subst Abuse Treat; 2015 Jan; 48(1):96-103. PubMed ID: 25175495
[TBL] [Abstract][Full Text] [Related]
14. Antinociceptive, subjective and behavioral effects of smoked marijuana in humans.
Greenwald MK; Stitzer ML
Drug Alcohol Depend; 2000 Jun; 59(3):261-75. PubMed ID: 10812286
[TBL] [Abstract][Full Text] [Related]
15. Marijuana's acute effects on cognitive bias for affective and marijuana cues.
Metrik J; Aston ER; Kahler CW; Rohsenow DJ; McGeary JE; Knopik VS
Exp Clin Psychopharmacol; 2015 Oct; 23(5):339-50. PubMed ID: 26167716
[TBL] [Abstract][Full Text] [Related]
16. Subjective, cognitive and cardiovascular dose-effect profile of nabilone and dronabinol in marijuana smokers.
Bedi G; Cooper ZD; Haney M
Addict Biol; 2013 Sep; 18(5):872-81. PubMed ID: 22260337
[TBL] [Abstract][Full Text] [Related]
17. Reinforcing effects of oral Delta9-THC in male marijuana smokers in a laboratory choice procedure.
Hart CL; Haney M; Vosburg SK; Comer SD; Foltin RW
Psychopharmacology (Berl); 2005 Sep; 181(2):237-43. PubMed ID: 15830233
[TBL] [Abstract][Full Text] [Related]
18. Effects of acute smoked marijuana on complex cognitive performance.
Hart CL; van Gorp W; Haney M; Foltin RW; Fischman MW
Neuropsychopharmacology; 2001 Nov; 25(5):757-65. PubMed ID: 11682259
[TBL] [Abstract][Full Text] [Related]
19. Dronabinol and marijuana in HIV-positive marijuana smokers. Caloric intake, mood, and sleep.
Haney M; Gunderson EW; Rabkin J; Hart CL; Vosburg SK; Comer SD; Foltin RW
J Acquir Immune Defic Syndr; 2007 Aug; 45(5):545-54. PubMed ID: 17589370
[TBL] [Abstract][Full Text] [Related]
20. Marijuana smoking: effect of varying delta 9-tetrahydrocannabinol content and number of puffs.
Azorlosa JL; Heishman SJ; Stitzer ML; Mahaffey JM
J Pharmacol Exp Ther; 1992 Apr; 261(1):114-22. PubMed ID: 1313866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
